Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | IDO1 | P14902 | 3/20 | 0.53 |
| ▸ | AGXT | P21549 | 2/20 | 0.53 |
| ▸ | APP | P05067 | 7/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15532554 | 0.96 | APP (0.57) | TDP1L3MBTL1IDO1AGXTAPP | |
| SCHEMBL16093231 | 0.96 | APP (0.57) | TDP1L3MBTL1IDO1AGXTAPP | |
| SCHEMBL4483666 | 0.89 | L3MBTL1 (0.59) | TDP1L3MBTL1IDO1AGXTAPP | |
| SCHEMBL8499580 | 0.87 | IDO1 (0.61) | TDP1L3MBTL1IDO1AGXTAPP | |
| SCHEMBL9234752 | 0.87 | L3MBTL1 (0.62) | TDP1L3MBTL1IDO1AGXTAPP | |
| SCHEMBL6551488 | 0.85 | L3MBTL1 (0.65) | TDP1L3MBTL1IDO1AGXTAPP | |
| SCHEMBL16614410 | 0.85 | L3MBTL1 (0.65) | TDP1L3MBTL1IDO1AGXTAPP | |
| SCHEMBL29285378 | 0.85 | L3MBTL1 (0.56) | TDP1L3MBTL1IDO1AGXTAPP | |
| SCHEMBL27089915 | 0.85 | L3MBTL1 (0.65) | TDP1L3MBTL1IDO1AGXTAPP | |
| SCHEMBL1009895 | 0.85 | L3MBTL1 (0.65) | TDP1L3MBTL1IDO1AGXTAPP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4647434-A1 | MODULATOR FOR PROMOTING BINDING OF BUTYROPHILIN 3A1/2A1 | Unicet Biotech Co., LLC (CN) | 2025-11-12 | — | — | EP | disclosed |
| US-20240360163-A1 | Nucleoside Prodrugs and Uses Related Thereto | UNIV EMORY (US) | 2024-10-31 | — | — | US | disclosed |
| US-12049474-B2 | Nucleoside prodrugs and uses related thereto | EMORY UNIVERSITY (US) | 2024-07-30 | — | — | US | disclosed |
| WO-2024146627-A1 | MODULATOR FOR PROMOTING BINDING OF BUTYROPHILIN 3A1/2A1 | 北京清辉联诺生物科技有限责任公司 | 2024-07-11 | — | — | WO | disclosed |
| CN-118317784-A | Pyrrolo-benzodiazepine derivative and conjugate thereof, and preparation method and application thereof | 江苏恒瑞医药股份有限公司 | 2024-07-09 | — | — | CN | disclosed |
| US-20240165259-A1 | BIOORTHOGONAL REACTION SUITABLE FOR CLICK/UNCLICK APPLICATIONS | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2024-05-23 | — | — | US | disclosed |
| EP-4320073-A1 | BIOORTHOGONAL REACTION SUITABLE FOR CLICK/UNCLICK APPLICATIONS | Dana-Farber Cancer Institute, Inc. (US) | 2024-02-14 | — | — | EP | disclosed |
| US-20240043467-A1 | 5'-SUBSTITUTED NUCLEOSIDE MONOPHOSPHATES, PRODRUGS THEREOF, AND USES RELATED THERETO | EMORY UNIVERSITY (US) | 2024-02-08 | — | — | US | disclosed |
| CN-117337267-A | Bioorthogonal reactions suitable for click/click cancellation applications | 达纳－法伯癌症研究所公司 | 2024-01-02 | — | — | CN | disclosed |
| EP-4204428-A1 | 5'-SUBSTITUTED NUCLEOSIDE MONOPHOSPHATES, PRODRUGS THEREOF, AND USES RELATED THERETO | Emory University (US) | 2023-07-05 | — | — | EP | disclosed |
| US-4584396-A | Substituted phenoxypropionates and herbicidal compositions | NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) | 1986-04-22 | — | — | US | disclosed |
| EP-0068260-B1 | SUBSTITUTED PHENOXYPROPIONATES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS HERBICIDES | NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) | 1986-03-05 | — | — | EP | disclosed |
| EP-0086392-B1 | HERBICIDAL AGENT CONTAINING METAMITRON IN COMBINATION WITH CERTAIN PHENOXYPROPIONIC-ACID ESTERS | BAYER AG (DE) | 1985-08-21 | — | — | EP | disclosed |
| US-4441913-A | PRE- AND POST-EMERGENCE | NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) | 1984-04-10 | — | — | US | disclosed |
| EP-0086392-A1 | Herbicidal agent containing metamitron in combination with certain phenoxypropionic-acid esters | BAYER AG (DE) | 1983-08-24 | — | — | EP | disclosed |
| EP-0084819-A2 | Herbicidal agents containing methabenzthiazuron in combination with certain phenoxypropionic acid esters | BAYER AG (DE) | 1983-08-03 | — | — | EP | disclosed |
| EP-0068260-A2 | Substituted phenoxypropionates, process for their preparation and their use as herbicides | NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) | 1983-01-05 | — | — | EP | disclosed |
| US-4008226-A | ANTIBIOTIC | AMERICAN HOME PRODUCTS CORPORATION (US) | 1977-02-15 | — | — | US | disclosed |
| US-3993768-A | FUNGICIDES | SYNTEX (U.S.A.) INC. (US) | 1976-11-23 | — | — | US | disclosed |
| US-3962215-A | PHOSPHORYLATION, ACYLATION, WATER, ACID CHLORIDE, ALCOHOL | AMERICAN HOME PRODUCTS CORPORATION (US) | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240360163-A1 | Nucleoside Prodrugs and Uses Related Thereto | PNPO, GSTO1, CYP2C18 | TDP1 1205/4885L3MBTL1 4216/4885IDO1 1110/4885 |
| US-12049474-B2 | Nucleoside prodrugs and uses related thereto | PNPO, GSTO1, CYP2C18 | TDP1 1205/4885L3MBTL1 4216/4885IDO1 1110/4885 |
| US-20240165259-A1 | BIOORTHOGONAL REACTION SUITABLE FOR CLICK/UNCLICK APPLICATIONS | CILK1, SYMPK, DCK | TDP1 3667/4885L3MBTL1 3251/4885IDO1 2753/4885 |
| US-20240043467-A1 | 5'-SUBSTITUTED NUCLEOSIDE MONOPHOSPHATES, PRODRUGS THEREOF, AND USES RELATED THERETO | PNP, ENTPD5, TYMP | TDP1 216/4885L3MBTL1 2121/4885IDO1 1733/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.